| Financial Year |
March 31 2023 |
| Monetary Funds |
4,747,425,033.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,911,508.98 |
| Accounts Receivable |
1,722,156,153.66 |
| Advances to Suppliers |
64,478,303.29 |
| Other Receivables |
43,183,786.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,669,619.39 |
| Dividend Receivable |
-- |
| Inventories |
839,740,097.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,979,879.97 |
| Other Current Assets |
64,146,470.91 |
| Total Current Assets |
7,492,214,978.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
13,272,420.67 |
| Long-term Equity Investment |
45,127,298.91 |
| Investment Properties |
-- |
| Fixed Assetes |
449,694,152.39 |
| Under-construction Projects |
231,038,729.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
545,620,107.71 |
| R&D expenses |
457,423,872.17 |
| Goodwill |
418,484,308.18 |
| Long-Term Deferred and Prepaid Expenses |
74,814,893.32 |
| Deferred Income Tax Assets |
48,083,139.33 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,290,147,098.27 |
| Total Assets |
10,782,362,076.77 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
213,009,619.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
268,313,634.32 |
| Taxes Payable |
73,459,711.48 |
| Interest Payable |
13,164.00 |
| Dividend Payable |
-- |
| Other payables |
48,279,179.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
62,858,064.93 |
| Other Current Liabilities |
15,012,717.32 |
| Sub-Total of Current Liabilities |
1,167,313,690.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
13,540,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
88,877,618.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
210,196,248.18 |
| Total Liabilities |
1,377,509,939.10 |
| Paid-In Capital(Or Share Stock) |
457,478,344.00 |
| Capital Surplus |
5,854,341,434.66 |
| Surplus Reserve |
115,141,968.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,260,082,009.76 |
| Minority Stockholder's Interest |
250,651,835.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,154,200,302.41 |
| Owner's Equity（Stockholder's Equity） |
9,404,852,137.67 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,782,362,076.77 |
